# Lyra Therapeutics (stock symbol: LYRA) Logo in transparent PNG and SVG formats

## Lyra Therapeutics Logo large

### Lyra Therapeutics Logo large Download PNG (38.49 KB)

![Lyra Therapeutics Logo large Download PNG (38.49 KB)](/img/orig/LYRA_BIG-e8901831.png)

### Lyra Therapeutics Logo large Download SVG (7.48 KB)

![Lyra Therapeutics Logo large Download SVG (7.48 KB)](/img/orig/LYRA_BIG-59048d45.svg)

## Lyra Therapeutics Logo icon format

### Lyra Therapeutics Logo icon format Download PNG (23.58 KB)

![Lyra Therapeutics Logo icon format Download PNG (23.58 KB)](/img/orig/LYRA-d7d3ba6f.png)

### Lyra Therapeutics Logo icon format Download SVG (1.64 KB)

![Lyra Therapeutics Logo icon format Download SVG (1.64 KB)](/img/orig/LYRA-0415d27a.svg)

## Lyra Therapeutics Logo large for dark backgrounds

### Lyra Therapeutics Logo large for dark backgrounds Download PNG (21.66 KB)

![Lyra Therapeutics Logo large for dark backgrounds Download PNG (21.66 KB)](/img/orig/LYRA_BIG.D-df844747.png)

### Lyra Therapeutics Logo large for dark backgrounds Download SVG (7.43 KB)

![Lyra Therapeutics Logo large for dark backgrounds Download SVG (7.43 KB)](/img/orig/LYRA_BIG.D-ba33f4ac.svg)

## Lyra Therapeutics Logo icon format for dark backgrounds

### Lyra Therapeutics Logo icon format for dark backgrounds Download PNG (14.46 KB)

![Lyra Therapeutics Logo icon format for dark backgrounds Download PNG (14.46 KB)](/img/orig/LYRA.D-c03b3efb.png)

### Lyra Therapeutics Logo icon format for dark backgrounds Download SVG (1.61 KB)

![Lyra Therapeutics Logo icon format for dark backgrounds Download SVG (1.61 KB)](/img/orig/LYRA.D-3045d5fe.svg)

## About Lyra Therapeutics

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

1. Website domain: lyratherapeutics.com
2. Employees: 60
3. Marketcap: $76.4 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
